Compare NEOG & BTT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NEOG | BTT |
|---|---|---|
| Founded | 1981 | 2012 |
| Country | United States | United Kingdom |
| Employees | N/A | N/A |
| Industry | Biotechnology: In Vitro & In Vivo Diagnostic Substances | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.4B |
| IPO Year | 1989 | N/A |
| Metric | NEOG | BTT |
|---|---|---|
| Price | $7.03 | $22.84 |
| Analyst Decision | Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $8.83 | N/A |
| AVG Volume (30 Days) | ★ 3.4M | 151.1K |
| Earning Date | 01-08-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 2.95% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $886,886,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $1.80 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $3.87 | $18.90 |
| 52 Week High | $13.41 | $21.86 |
| Indicator | NEOG | BTT |
|---|---|---|
| Relative Strength Index (RSI) | 58.67 | 64.14 |
| Support Level | $7.01 | $22.24 |
| Resistance Level | $7.29 | $22.54 |
| Average True Range (ATR) | 0.25 | 0.17 |
| MACD | -0.03 | 0.05 |
| Stochastic Oscillator | 41.19 | 85.48 |
Neogen Corporation, headquartered in Lansing, Michigan, develops, manufactures, and markets various products for food and animal safety. In food safety, the company performs diagnostics to detect unintended substances in food and animal feed, to prevent contamination and foodborne illnesses such as foodborne pathogens, spoilage organisms, natural toxins, food allergens, and ruminant by-products. In animal safety, the company segment is engaged in the development, manufacture, marketing and distribution of veterinary instruments, pharmaceuticals, vaccines, topicals, parasiticides, diagnostic products, rodent control products, cleaners, disinfectants, insect control products and genomics testing services.
Blackrock Municipal 2030 Target Term Trust is a United States-based closed-end management investment company. The investment objective of the company is to provide current income exempt from regular federal income tax and to return $25.00 per common share to holders of common shares. The trust seeks to achieve its investment objectives by investing a majority of its assets in municipal bonds exempt from U.S. federal income taxes.